Yolanda J.
- Country
- Spain
- Department
- Pediatric Intensive Care
Research Overview
- A Phase 1, open-label, non-comparative, multicenter clinical study to evaluate the safety, tolerability, and pharmacokinetics of ceftolozane/tazobactam (MK-7625A) in pediatric participants with nosocomial pneumonia
- Angiotensin II for Refractory Hypotension in Paediatric Patients With Distributive Shock: A Phase III Randomised Placebo-Controlled Trial
- Phase 1b Randomized, Double-Blind, Placebo-Controlled Study of Sisunatovir in Pediatric Patients with RSV Lower Respiratory Tract Infection
Data & Insights
Has run more than one trial at 3 of 32 partner sites.
Specializations
Respiratory Disease Research
The investigator specializes in studying respiratory syncytial virus (RSV) infections, with particular emphasis on lower respiratory tract infections in pediatric populations.
- Pediatric Respiratory Infections
- RSV Treatment Development
- Infant Respiratory Care
Active involvement in evaluating novel therapeutic approaches for respiratory viral infections in vulnerable age groups.
Pediatric Medicine
Focuses on advancing therapeutic solutions for infant and child respiratory conditions, with expertise in treating acute respiratory infections in young patients.
- Infant Healthcare
- Pediatric Clinical Care
- Child Respiratory Health
Dedicated to investigating safe and effective treatments for pediatric respiratory diseases.
Therapeutic Development
Engages in research evaluating novel antiviral treatments and their safety profiles in pediatric populations affected by respiratory infections.
- Drug Safety Assessment
- Therapeutic Tolerability
- Clinical Pharmacology
Specialized in assessing therapeutic interventions for respiratory viral infections.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.